John D Couling, Senior Vice President, Entertainment, on June 01, 2026, sold 7,666 shares in Dolby Laboratories (DLB) for $426,420. Following the Form 4 filing with the SEC, Couling has control over a total of 118,727 Class A common shares of the company, with 118,727 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1308547/000119312526255624/xslF345X05/ownership.xml
Kyle McLaughlin, Executive Vice President, Aviation, on June 02, 2026, sold 8,000 shares in Clear Secure (YOU) for $449,600. Following the Form 4 filing with the SEC, McLaughlin has control over a total of 29,519 Class A common shares of the company, with 29,519 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1856314/000200963626000003/xslF345X05/wk-form4_1780519477.xml
John Q Doyle, President and CEO, on June 02, 2026, sold 16,656 shares in Marsh & Mclennan Companies (MRSH) for $2,693,442. Following the Form 4 filing with the SEC, Doyle has control over a total of 116,811 common shares of the company, with 116,811 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/62709/000006270926000164/xslF345X05/form4.xml
Martine A Rothblatt, Director, Chairperson & CEO, on June 02, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,114,742. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000110657826000068/xslF345X05/primarydocument.xml